Benjamin Y. Kong
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Cutaneous Melanoma Detection and Management
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Co-authors
- Matteo Salvatore Carlino (10 shared papers)Richard F. Kefford (7 shared papers)Alexander Maxwell Menzies (5 shared papers)Georgina Venetia Long (6 shared papers)Elizabeth Liniker (6 shared papers)Shelley Ji Eun Hwang (2 shared papers)Shaun Chou (2 shared papers)Pablo Fernández‐Peñas (2 shared papers)
- Journals
- BMJ Open (3 papers)Frontiers in Oncology (3 papers)European Journal of Cancer (2 papers)American Journal of Physiology-Cell Physiology (2 papers)Biochemistry (2 papers)
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
Benjamin Y. Kong
41 papers receiving 2.7k citations
Benjamin Y. Kong's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 1.9k
- Immunology 608
- Pulmonary and Respiratory Medicine 507
- Genetics 127
- Dermatology 75
Countries citing papers authored by Benjamin Y. Kong
This map shows the geographic impact of Benjamin Y. Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Y. Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Y. Kong more than expected).
Fields of papers citing papers by Benjamin Y. Kong
This network shows the impact of papers produced by Benjamin Y. Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Y. Kong. The network helps show where Benjamin Y. Kong may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Y. Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy Hit paper breakdown → | 2016 | 938 |
| 2 | 2018 | 282 | |
| 3 | 2016 | 263 | |
| 4 | 2017 | 220 | |
| 5 | 2017 | 211 | |
| 6 | 2016 | 141 | |
| 7 | 2016 | 107 | |
| 8 | 2016 | 78 | |
| 9 | 2016 | 74 | |
| 10 | 2018 | 54 | |
| 11 | 2021 | 50 | |
| 12 | 2016 | 32 | |
| 13 | 2018 | 32 | |
| 14 | 2007 | 31 | |
| 15 | 2018 | 29 | |
| 16 | 2004 | 24 | |
| 17 | 2002 | 21 | |
| 18 | 2004 | 21 | |
| 19 | 2023 | 18 | |
| 20 | 2019 | 14 |
About Benjamin Y. Kong
Benjamin Y. Kong is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 41 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (10 papers), Glioma Diagnosis and Treatment (8 papers), Immunotherapy and Immune Responses (5 papers), Melanoma and MAPK Pathways (5 papers), Brain Metastases and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Ion channel regulation and function (3 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (608 citations), Pulmonary and Respiratory Medicine (507 citations), Genetics (127 citations) and Dermatology (75 citations). Benjamin Y. Kong has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Matteo Salvatore Carlino, Richard F. Kefford, Alexander Maxwell Menzies, Georgina Venetia Long, Elizabeth Liniker, Shelley Ji Eun Hwang, Shaun Chou, Pablo Fernández‐Peñas, Giuliana Carlos and Deepal Wakade. Their work appears in journals such as BMJ Open, Frontiers in Oncology, European Journal of Cancer, American Journal of Physiology-Cell Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.